David T. Drummond ⎜Sep 15, 2016 ⎜ Market
“This is a period of profound change for the Mo-99 supply network that is key to our industry.” – David Drummond, Managing Director and Founder of isoSolutions.
September 13, 2016 — Supplies of a key radioisotope used in nuclear cardiology scans could be disrupted next month when a Canadian nuclear reactor begins shutting down. U.S. healthcare providers could be left scrambling for new sources of molybdenum-99 (Mo-99) until other suppliers are able to step in and fill the void. (more…)